A masked, randomised clinical trial evaluating the efficacy and safety of lokivetmab compared to saline control in client‐owned dogs with allergic dermatitis

por Van Brussel, Leen, Moyaert, Hilde, Escalada, Monica, Mahabir, Sean P., Stegemann, Michael R.
Publicado 2021

Efficacy of oclacitinib (Apoquel®) compared with prednisolone for the control of pruritus and clinical signs associated with allergic dermatitis in client-owned dogs in Australia

por Gadeyne, Caroline, Little, Peter, King, Vickie L, Edwards, Nigel, Davis, Kylie, Stegemann, Michael R
Publicado 2014

A blinded, randomized clinical trial comparing the efficacy and safety of oclacitinib and ciclosporin for the control of atopic dermatitis in client-owned dogs

por Little, Peter R, King, Vickie L, Davis, Kylie R, Cosgrove, Sallie B, Stegemann, Michael R
Publicado 2015

Comparative efficacy of tulathromycin and tildipirosin for the treatment of experimental Mycoplasma bovis infection in calves

por Bartram, David J., Moyaert, Hilde, Vanimisetti, Bindu H., Ramage, Clifford P., Reddick, David, Stegemann, Michael R.
Publicado 2016

A blinded, randomized, placebo‐controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel(®)) in client‐owned dogs with atopic dermatitis

por Cosgrove, Sallie B., Wren, Jody A., Cleaver, Dawn M., Walsh, Kelly F., Follis, Stacey I., King, Vickie I., Tena, Jezaniah‐Kira S., Stegemann, Michael R.
Publicado 2013

Efficacy and safety of oclacitinib for the control of pruritus and associated skin lesions in dogs with canine allergic dermatitis

por Cosgrove, Sallie B, Wren, Jody A, Cleaver, Dawn M, Martin, David D, Walsh, Kelly F, Harfst, Jessica A, Follis, Stacey L, King, Vickie L, Boucher, Joseph F, Stegemann, Michael R
Publicado 2013